The U.S. FDA officially authorizes the usage of a third dosage of the Pfizer–BioNTechCOVID-19 vaccine as a booster shot for individuals still considered vulnerable to COVID-19. Among those eligible are health care workers and senior citizens who have been fully inoculated with the vaccine for at least six months.
The U.S. FDA announces the approval of a booster dose of the Pfizer–BioNTech COVID-19 vaccine for people aged 65 and older.
The U.S. FDA officiallyauthorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine asaboostershotfor individualsstillconsideredvulnerabletoCOVID-19.Amongthoseeligible are healthcareworkersand seniorcitizenswhohavebeenfullyinoculatedwiththevaccineforatleastsixmonths.